Professor Michael Parker

“Sustainable and appropriate innovation depends upon the identification, analysis and addressing of important ethical issues”

Michael Parker is Professor of Bioethics and Director of the Ethox Centre at the University of Oxford. His main research interest is in the ethics of collaborative global health research. Together with partners at the Wellcome Trust Major Overseas Programmes (MOPs) in Viet Nam, Malawi, Thailand-Laos, Kenya, and South Africa he co-ordinates the Global Health Bioethics Network – which is a programme to carry out ethics research and build ethics capacity across the MOPs. The Global Health Bioethics Network is funded through a Wellcome Trust Strategic Award. Michael also leads the ethics programme of the Malaria Genomic Epidemiology Network (MalariaGEN) – which carries out genomic research into severe malaria in childhood at more than 30 sites in 21 countries.

Michael’s other main research interest is in the ethical aspects of the clinical use of genetics. Since 2001, he has – with Anneke Lucassen, Tara Clancy and Angus Clarke – co-ordinated the Genethics Club which is a national ethics forum for health professionals and genetics laboratory staff in theUnited Kingdom to discuss the ethical issues arising in their day-to-day practice and to share good practice.

Michael is on a number of committees and working parties. He is currently Chair of the Consortium Data Access Committee of the Wellcome Trust Case Control Consortium; member of the Medical Research Council’s Ethics, Regulation and Public Involvement Committee; and, member of Department of Health’s Committee for the Ethical Aspects of Pandemic Influenza. He is also an ethics consultant to UK Biobank. He has previously been a member of a number of national and international committees and working parties including: the Nuffield Council of Bioethics Working Group on Mitochondrial Donation; the Ethics in Practice Committee of the Royal College of Physicians; Lord Warner’s Ad Hoc Advisory Committee on Research Ethics; the Ministerial Task Force on the Summary Care Record; the Academy of Medical Sciences Working Party on the regulation of medical research; the Royal College of Physicians Working Party on Clinical Ethics Committees; and, the Board of Directors of the International Association of Bioethics.

Email Professor Michael Parker